
Loading, please wait...

Loading, please wait...

Recent research has identified retinal neurodegeneration in epilepsy as a critical area of study, with the retinal nerve fiber layer (RNFL) serving as a potential surrogate marker for brain health. Since the retina is embryologically an extension of the central nervous system, changes in its structure often mirror pathological processes occurring within the brain. This association provides a non-invasive window into the neurodegenerative effects of chronic seizure activity.
A recent case-control study compared 53 patients with epilepsy against 50 healthy controls to evaluate retinal health. Using Spectral Domain Optical Coherence Tomography (SD-OCT), researchers measured the peripapillary RNFL thickness across various quadrants. The results showed that patients with epilepsy had significantly reduced thickness in the superior, inferior, and average RNFL regions in both eyes compared to the control group.
Furthermore, the study explored how disease characteristics influence these structural changes. Researchers observed a strong negative correlation between RNFL thickness and both the duration of epilepsy and the frequency of seizures. Specifically, patients who experienced more frequent seizures or had lived with the condition for longer periods exhibited more pronounced thinning of the retinal layers. Consequently, this suggests that the cumulative burden of epilepsy contributes directly to progressive axonal loss.
Beyond physical measurements, the study also utilized the Montreal Cognitive Assessment (MOCA) scale to evaluate mental function. Interestingly, thinner RNFL measurements correlated significantly with lower MOCA scores. This finding indicates that retinal thinning is not just an isolated ocular finding but a marker of broader cognitive decline and systemic neurodegeneration.
Additionally, SD-OCT serves as a highly accessible and objective tool for clinicians. While traditional seizure frequency reports can be subjective or unreliable, retinal imaging offers a quantifiable metric. Monitoring these changes over time might help neurologists and ophthalmologists better understand the disease progression and the potential impact of anti-seizure medications on neuronal integrity. Notably, integrating retinal imaging into routine neurological care could improve early detection of neurocognitive deterioration.
Epilepsy causes thinning through a process called retrograde trans-synaptic degeneration. Repeated seizure activity leads to excitotoxic stress and neuronal damage in the brain, which then spreads along the visual pathways to the retina, resulting in measurable axonal loss.
Yes, SD-OCT scans provide an objective measure of neuroaxonal loss. Clinicians can use these scans to monitor disease severity, assess the risk of cognitive decline, and potentially evaluate the long-term neuroprotective or neurotoxic effects of various treatment regimens.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always consult a qualified healthcare provider for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Masoud MM et al. Retinal Nerve Fiber Layer Thickness as a Marker of Neurodegeneration in Epilepsy. Int J Neurosci. 2026 Apr 30. doi: 10.1080/00207454.2026.2664786. PMID: 42060940.
Delazer L, Bao H, Lauseker M, et al. Association between retinal thickness and disease characteristics in adult epilepsy: a cross-sectional OCT evaluation. Epilepsia Open. 2023;8(4):1456-1467. doi: 10.1002/epi4.12814.
Mekkawy DA, Rabah AM, Hegazy M, et al. Role of optical coherence tomography as a diagnostic marker for neurodegeneration in epilepsy: a cross-sectional analytical study. Egypt J Neurol Psychiatry Neurosurg. 2024;60:82. doi: 10.1186/s41983-024-00861-5.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research confirms that RNFL thinning serves as a significant biomarker for retinal neurodegeneration in epilepsy, correlating with cognitive decline....
5 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today